The global lateral flow assays market value was US$ 8,341.30 million in 2020. The global lateral flow assays market value is forecast to reach US$ 13,342.90 million by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2021-2030.
A lateral flow assay (LFA), also known as an immunochromatographic assay, is a technique that detects the presence (or absence) of analytes in a sample (matrix). Various clinical laboratories and hospitals use these assays extensively for detecting antigens and antibodies in a qualitative and quantitative manner. In addition, lateral flow assay kits allow rapid detection of infectious diseases, cardiac markers, pregnancy & fertility, cholesterol testing, lipid profiling, and drug abuse.
Factors Influencing Market Growth
Impact Analysis of COVID-19
Due to the COVID-19 pandemic, the lateral flow assays (LFA) market has experienced significant growth. Worldwide, the use of LFA-based tests to diagnose COVID-19 infections is increasing because the test kits have demonstrated their ability to detect both symptomatic and asymptomatic infections. Since LFA-based devices are inexpensive and don't require trained personnel to perform, they are increasingly popular. Among other detection methods, LFA devices have the potential to detect symptomatic and asymptomatic COVID-19 infections. Additionally, LFA-based tests can diagnose COVID-19 disease at various stages in a patient. Therefore, LFA-based tests influence medical and economic decisions for countries dealing with the COVID-19 pandemic or preparing for a third wave.
Regional Insights
Geographically, North America held dominance in the global lateral flow assays market by revenue in 2020. Streamlined lateral flow assays have become readily available and highly affordable due to their ease of use and affordability. COVID-19, influenza, and RSV are also driving the need for detection and treatment in the region. In addition, the well-established healthcare infrastructure of this region, and government funding for research, are likely to help drive the market growth for lateral flow assays.
Over the forecast period, Asia Pacific is forecast to grow at the fastest rate. Due to the high prevalence of chronic and infectious diseases in Asian countries and the emergence of new players, demand is likely to rise for this regional market. Additionally, a rise in approvals for different infectious disease tests is forecast to boost the market growth in the next few years.
Leading Competitors
The leading prominent companies profiled in the global lateral flow assays market are:
Scope of the Report
The global lateral flow assays market segmentation focuses on Technique, Product, Application, End-User, and Region.
Segmentation based on Technique
Segmentation based on Product
Segmentation based on Application
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL LATERAL FLOW ASSAYS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL LATERAL FLOW ASSAYS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE
5.1 OVERVIEW
5.2 SANDWICH ASSAYS
5.3 COMPETITIVE ASSAYS
5.4 MULTIPLEX DETECTION ASSAYS
6 GLOBAL LATERAL FLOW ASSAYS MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 KITS & REAGENTS
6.3 LATERAL FLOW READERS
6.3.1 DIGITAL/MOBILE READERS
6.3.2 BENCHTOP READERS
6.3.3 MOBILE/SMARTPHONE READERS
7 GLOBAL LATERAL FLOW ASSAYS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CLINICAL TESTING
7.2.1 INFECTIOUS DISEASE TESTING
7.2.2 CARDIAC MARKER TESTING
7.2.3 PREGNANCY & FERTILITY TESTING
7.2.4 CHOLESTEROL TESTING/LIPID PROFILE
7.2.5 DRUG ABUSE TESTING
7.2.6 OTHER CLINICAL TESTS
7.3 VETERINARY DIAGNOSTICS
7.4 FOOD SAFETY & ENVIRONMENT TESTING
7.5 DRUG DEVELOPMENT & QUALITY TESTING
8 GLOBAL LATERAL FLOW ASSAYS MARKET, BY END-USER
8.1 OVERVIEW
8.2 HOSPITALS & CLINICS
8.3 DIAGNOSTIC LABORATORIES
8.4 HOME CARE
8.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.6 OTHERS
9 GLOBAL LATERAL FLOW ASSAYS MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA MARKET SNAPSHOT
9.2.2 U.S.
9.2.3 CANADA
9.2.4 MEXICO
9.3 EUROPE
9.3.1 EUROPE MARKET SNAPSHOT
9.3.2 WESTERN EUROPE
9.3.2.1 THE UK
9.3.2.2 GERMANY
9.3.2.3 FRANCE
9.3.2.4 ITALY
9.3.2.5 SPAIN
9.3.2.6 REST OF WESTERN EUROPE
9.3.3 EASTERN EUROPE
9.3.3. 1 POLAND
9.3.3.2 RUSSIA
9.3.3.3 REST OF EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC MARKET SNAPSHOT
9.4.2 CHINA
9.4.3 JAPAN
9.4.4 INDIA
9.4.5 AUSTRALIA & NEW ZEALAND
9.4.6 ASEAN
9.4.7 REST OF ASIA PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
9.5.2 UAE
9.5.3 SAUDI ARABIA
9.5.4 SOUTH AFRICA
9.5.5 REST OF MEA
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA MARKET SNAPSHOT
9.6.2 BRAZIL
9.6.3 ARGENTINA
9.6.4 REST OF SOUTH AMERICA
10 GLOBAL LATERAL FLOW ASSAYS MARKET COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPANY MARKET RANKING
10.3 KEY DEVELOPMENT STRATEGIES
11 COMPANY PROFILES
11.1 ABBOTT
11.1.1 OVERVIEW
11.1.2 FINANCIAL PERFORMANCE
11.1.3 PRODUCT OUTLOOK
11.1.4 KEY DEVELOPMENTS
11.2 BECTON, DICKINSON, AND COMPANY
11.2.1 OVERVIEW
11.2.2 FINANCIAL PERFORMANCE
11.2.3 PRODUCT OUTLOOK
11.2.4 KEY DEVELOPMENTS
11.3 BIOMÉRIEUX SA
11.3.1 OVERVIEW
11.3.2 FINANCIAL PERFORMANCE
11.3.3 PRODUCT OUTLOOK
11.3.4 KEY DEVELOPMENTS
11.4 BIO-RAD LABORATORIES, INC.
11.4.1 OVERVIEW
11.4.2 FINANCIAL PERFORMANCE
11.4.3 PRODUCT OUTLOOK
11.4.4 KEY DEVELOPMENTS
11.5 DANAHER CORPORATION
11.5.1 OVERVIEW
11.5.2 FINANCIAL PERFORMANCE
11.5.3 PRODUCT OUTLOOK
11.5.4 KEY DEVELOPMENTS
11.6 F. HOFFMANN-LA ROCHE AG
11.6.1 OVERVIEW
11.6.2 FINANCIAL PERFORMANCE
11.6.3 PRODUCT OUTLOOK
11.6.4 KEY DEVELOPMENTS
11.7 HOLOGIC, INC.
11.7.1 OVERVIEW
11.7.2 FINANCIAL PERFORMANCE
11.7.3 PRODUCT OUTLOOK
11.7.4 KEY DEVELOPMENTS
11.8 MERCK KGAA
11.8.1 OVERVIEW
11.8.2 FINANCIAL PERFORMANCE
11.8.3 PRODUCT OUTLOOK
11.8.4 KEY DEVELOPMENTS
11.9 PERKINELMER, INC.
11.9.1 OVERVIEW
11.9.2 FINANCIAL PERFORMANCE
11.9.3 PRODUCT OUTLOOK
11.9.4 KEY DEVELOPMENTS
11.10 QIAGEN N.V
11.10.1 OVERVIEW
11.10.2 FINANCIAL PERFORMANCE
11.10.3 PRODUCT OUTLOOK
11.10.4 KEY DEVELOPMENTS
11.11 QUIDEL CORPORATION
11.11.1 OVERVIEW
11.11.2 FINANCIAL PERFORMANCE
11.11.3 PRODUCT OUTLOOK
11.11.4 KEY DEVELOPMENTS
11.12 SIEMENS HEALTHINEERS
11.12.1 OVERVIEW
11.12.2 FINANCIAL PERFORMANCE
11.12.3 PRODUCT OUTLOOK
11.12.4 KEY DEVELOPMENTS
11.13 THERMO FISHER SCIENTIFIC, INC.
11.13.1 OVERVIEW
11.13.2 FINANCIAL PERFORMANCE
11.13.3 PRODUCT OUTLOOK
11.13.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved